ArticleJournal of thoracic disease2025
TTF-1 expression stratifies chemoimmunotherapy benefits in PD-L1-negative lung adenocarcinoma: a real-world biomarker validation.
Ning Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.